Dynavax Technologies Corp $1.45

up +0.01


22/9/2014 10:46 AM  |  NASDAQ : DVAX  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get DVAX Trend Analysis - it has outperformed the S&P 500 by 5%

Partner Headlines

  1. Two Promising Health Care Stocks with Market Capitalizations Under $50 ...

    GuruFocus
  2. US Stock Futures Edge Higher Ahead Of Earnings

    Benzinga
  3. Dynavax Initiates Phase 3 Study of HEPLISAV-B

    Benzinga
  4. After-Hours Movers Mar. 5, 2014: ERII, PXLW, BIOD, SEED Higher, DVAX, LYV ...

    Benzinga
  5. Jefferies Reiterates on Dynavax Technologies Awaiting Initiation of HBV-23 ...

    Benzinga
  6. Top Three Largest Insider Buys of the Past Week

    GuruFocus
  7. Dynavax Issues Update on HEPLISAV's Regulatory Path, Will Host Call Tomorrow

    Benzinga
  8. Dynavax Says Phase 3 Data on HEPLISAV for Adults Age 40-70 Published in ...

    Benzinga
  9. Insiders Are Buying Idera Pharmaceuticals

    GuruFocus
  10. Mid-Afternoon Market Update: NuVasive Rises While EXCO Resourced Drops

    Benzinga
  11. Mid-Day Market Update: Markets Remain Up, Dynavax Continues Rally

    Benzinga
  12. Benzinga's Top Initiations

    Benzinga
  13. Dynavax Bears Load Up on Put Options

    SchaeffersResearch
  14. Benzinga's Top Pre-Market Losers

    Benzinga
  15. Dynavax: Little Stock With a Big Story – Plunge a Buy Opportunity?

    YCharts
  16. Mid-Afternoon Market Update: Markets Recovering; Penn National Gaming Still ...

    Benzinga
  17. Mid-Day Markets Update: Markets Recover on Fiscal Cliff Meeting; Casino ...

    Benzinga
  18. UPDATE: Jefferies & Company Reiterates Buy Rating, Lowers PT on Dynavax ...

    Benzinga
  19. Mid-Morning Market Update: Markets Down; Casino Equities Get a Boost

    Benzinga
  20. Mid-Afternoon Market Update: Markets Go Red; Ak Steel Plunges Again

    Benzinga
  21. Benzinga's Top Initiations

    Benzinga
  22. Dynavax Technologies Corp. Reports Operating Results (10-Q)

    GuruFocus
  23. Dynavax to Initiate Phase 1 Studies For TLR-9 Agonist For Asthma

    Benzinga
  24. Benzinga Mid-Morning Market Update

    Benzinga
  25. Dynavax Tech Names Larson CFO

    Benzinga
  26. Dynavax Technologies Corp. Reports Operating Results (10-Q)

    GuruFocus
  27. Dynavax Prices Public Offering of Common Stock; 17.5M Shares at $4.25/Share

    Benzinga
  28. Dynavax Initiates Proof of Mechanism Trial in Lupus Patients

    Benzinga
Trading Center